SEPTInvestingStart Free
Stocks/CRMD/SEC Filings/8-K Nov 9, 2026

CRMD 8-K: Acquisition

CorMedix Inc.

Filed with the SEC on Nov 9, 2026 · accession 0001213900-26-117213

CRMD filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -2.6% by the first close after the filing.

Summary of the filing

CorMedix Inc. entered into an Asset Purchase Agreement to acquire substantially all of the assets of Heron Therapeutics, Inc. for $145.0 million in cash plus 14,583,333 shares of CorMedix common stock, along with royalty and earn-out payments tied to future net sales of certain products.

For details, click here →How to read a 8-K →

Key details

Cash consideration for asset acquisition$145.0M
Escrow deposit securing post-closing adjustments$2.0M
Maximum post-closing adjustment to cash consideration$10.0M
Earn-out payment if 2028 ZYNRELEF net sales equal or exceed $65.0 million$25.0M
Additional earn-out payment if 2028 ZYNRELEF net sales equal or exceed $95.0 million$30.0M
AcquirerCorMedix Inc.
SellerHeron Therapeutics, Inc.
Escrow agentCitibank, N.A.

How CRMD stock reacted

Close before

$5.32

Nov 6, 2026

First close after

-2.63%

$5.18

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CRMD, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CRMD?

Click here

Frequently asked questions

What did CRMD file with the SEC on Nov 9, 2026?

CRMD filed a 8-K (Acquisition). CorMedix Inc. entered into an Asset Purchase Agreement to acquire substantially all of the assets of Heron Therapeutics, Inc. for $145.0 million in cash plus 14,583,333 shares of CorMedix common stock, along with royalty and earn-out payments tied to future net sales of certain products.

What does a acquisition mean for CRMD stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did CRMD stock react to this filing?

CRMD closed at $5.32 before the filing and $5.18 on Nov 9, 2026 (-2.63%).

Other CRMD SEC filings

  • 8-K · SEC filingNov 2, 2026
  • 8-K · Fda approvalOct 19, 2026
  • 10-Q · Material agreementAug 13, 2026
  • 8-K · SEC filingAug 13, 2026
  • 8-K · Legal settlementAug 7, 2026
  • 8-K · Executive departureJul 2, 2026
  • 8-K · Auditor changeJul 1, 2026
  • 8-K · SEC filingJun 24, 2026
  • 8-K · Legal settlementJun 8, 2026
  • 8-K · SEC filingMay 14, 2026

Get alerts when CRMD files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
CRMD overviewCRMD analysisCRMD newsLatest SEC filings
Source: SEC EDGAR filing 0001213900-26-117213. The summary and key details are extracted by SEPT from the filing and may contain errors. Price reaction uses daily closing prices. Not financial advice.